The Rush Stroke Program was recertified with the Joint Commission's Gold Seal of Approval and the American Heart Association’s Heart-Check mark for Advanced Certification for Comprehensive Stroke Centers.
The Rush Midlife Center provides women transitioning through perimenopause with a specialized resource they can turn to for diagnosis, treatment and support. It is one of only five such comprehensive, multidisciplinary centers in the United States.
Mechanical thrombectomy, a treatment to remove a stroke-causing blood clot in the brain, is effective in some patients even when performed within six to 24 hours after a stroke, according to the results of an international research study.
Neurologists at the Rush Alzheimer’s Disease Center are conducting an 18-month clinical trial testing a type of insulin delivered in a nasal spray – which is used to treat diabetes in some patients — in the Study of Nasal Insulin to Fight Forgetfulness (SNIFF).
Rush University Medical Center and Rush-Copley Medical Center (Rush-Copley) have completed the process of reorganizing their operations under a common corporate parent led by a board of trustees that will oversee the fully integrated Rush academic health system (Rush).
The Parkinson's Foundation today announced the addition of Rush University Medical Center to its global network of institutions the foundation has designated as Centers of Excellence. The newest designation builds upon Rush’s longstanding history and recognition as a Parkinson's Foundation Research Center.
Rush University Medical Center unveiled a unique mobile stroke treatment unit, a specially built, state-of-the-art ambulance outfitted with telemedicine technology and a CT scanner enabling brain imaging that is critical to accurate stroke diagnoses and treatment.
Physicians at Rush University Medical Center became the first in Illinois to inject AST-OPC1 (oligodendrocyte progenitor cells), an experimental treatment, into the damaged cervical spine of a recently paralyzed man as part of a multicenter clinical trial.
Diseased blood vessels in the brain, which commonly is found in elderly people, may contribute more significantly to Alzheimer's disease dementia than was previously believed, according to results of a Rush study that recently were published in The Lancet Neurology.